论文部分内容阅读
我院内科自1986年6月至1991年12月共遇肺肿瘤咯血死亡8例,现报告如下。临床资料男7例,女1例,平均年龄52.3岁(19～62岁);8例中6例为原发性肺癌,2例为转移性肺癌(一例为恶淋白血病伴肺浸润,另一例为右肾癌肺转移),在6例原发肺癌中有4例为肺鳞癌,1例为肺小细胞未分化癌,1例为肺腺癌;8例中有7例病灶位于右上肺或右肺门,1例位于左上肺;全部病例中仅有3例有明确诱因(均在“解便“后),其余无明确诱因。8例中,有4例在致死性咯血前有少量咯血史,另4例从无咯血史。本组病例的致死性咯血量150～1500ml 不等(平均咯血量950ml)。
In our department of internal medicine, from June 1986 to December 1991, a total of 8 cases of hemoptysis died of lung cancer. The current report is as follows. The clinical data were 7 males and 1 female, with an average age of 52.3 years (19-62 years old); 6 of 8 cases were primary lung cancer, and 2 cases were metastatic lung cancer (one case was leukemia with lung infiltration, and the other was In the case of right kidney cancer and lung metastases, 4 of the 6 primary lung cancers were squamous cell carcinoma of the lung, 1 was lung small cell undifferentiated carcinoma, 1 was lung adenocarcinoma; 7 of 8 cases were located in the right upper lung Or the right hilum, 1 case was located in the left upper lung; only 3 cases in all cases had clear incentives (all after “solution”), and the rest had no clear incentive. Of the 8 cases, 4 cases had a history of hemoptysis before lethal hemoptysis, and 4 cases had no history of hemoptysis. This group of cases of fatal hemoptysis ranging from 150 to 1500ml (mean hemoptysis 950ml).